Cargando...
Antisense Therapie Neurologischer Erkrankungen
There are few disease-modifying therapeutics for neurodegenerative diseases. Antisense oligonucleotide (ASO) therapeutics for spinal muscular atrophy, Duchenne muscular dystrophy, and transthyretin amyloidosis predict a robust future for ASOs in medicine. Perhaps the most significant advantage to AS...
Guardado en:
| Publicado en: | Nervenarzt |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6730669/ https://ncbi.nlm.nih.gov/pubmed/31165208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00115-019-0724-4 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|